No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
PFE241213P26500
- 1.10
- +0.24+27.91%
15min DelayTrading Dec 11 10:00 ET
1.11High1.08Low
1.08Open0.86Pre Close153 Volume833 Open Interest26.50Strike Price16.58KTurnover0.00%IV0.18%PremiumDec 13, 2024Expiry Date1.06Intrinsic Value100Multiplier2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma24.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Express News | Reuters Next - Pfizer's Roan Says We Need to Get Behind the Disease Prevention Message
Express News | Reuters Next - Pfizer's Roan Says Going to Work Hard to Ensure Ecosystem That Drives Vaccines & New Medicines Is Robust and Healthy
Express News | Reuters Next - Pfizer Chief Sustainability Officer Caroline Roan Says Need to Double Down on Climate Investments in Low Income Countries
Guggenheim Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $33
Evercore Maintains Pfizer(PFE.US) With Buy Rating
Pfizer (PFE) Gets a Buy From Evercore ISI